Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRADIMED CORPIRMD · Entity 4896 | VP Manufacturing | February 20, 2020 | February 24, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRADIMED CORP
Report date February 20, 2020 · Filed February 24, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-02-20 transaction · row 1
1 source rowRow 1 · 2020-02-20 · Sale · Disposed 1,715 · Balance 0 F1: This transaction was executed in multiple trades at prices ranging from $26.18 to $26.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $26.18 to $26.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2020 Filed Feb 24, 2020 17:06 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,715 | $26.19 | $44,915.85 |
DisclosureSEC source: 0000898432-20-000124 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.18 to $26.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:30 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000019 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:30 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 95 | $23.38 | $2,221.10 |
DisclosureSEC source: 0000898432-20-000019 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,715 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:30 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000019 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 183 | $25.67 | $4,697.61 |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · derivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 2,185 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Underlying: Common Stock · 2,185 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 96 | $22.88 | $2,196.48 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:23 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001350 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:23 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $22.28 | $4,010.40 |
DisclosureSEC source: 0000898432-19-001350 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558 Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:23 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001350 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 17:36 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,250 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-19-001295 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 5,000 shares, was granted on 12/15/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 17:36 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,250 | $24.36 | $30,450.00 |
DisclosureSEC source: 0000898432-19-001295 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $24.32 to $24.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 17:36 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 1,250 | $9.84 | $12,300.00 |
DisclosureSEC source: 0000898432-19-001295 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 16:45 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,418 | $26.07 | $36,961.16 |
DisclosureSEC source: 0000898432-19-000364 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.135. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 95 | $24.46 | $2,323.70 |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 183 | $27.02 | $4,944.66 |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:33 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001457 · form4.xml · derivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 6 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 2,188 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 5,000 shares, was granted on 12/15/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 5 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/13/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 7,662 | $23.80 | $182,349.47 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.75 to $23.975. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 2,500 | $9.84 | $24,600.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,662 Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 4,376 | $1.48 | $6,476.48 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,162 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Unit · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 107 | $15.15 | $1,621.05 |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 245 | $13.10 | $3,209.50 |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:43 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045229 · doc1.xml · derivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,187 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 7 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188 Underlying: Common Stock · 2,187 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/13/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 253 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 6 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188 Underlying: Common Stock · 253 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,700 | $8.30 | $22,410.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 2,440 | $1.48 | $3,611.20 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,934 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · derivative · entry 5 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,441 Underlying: Common Stock · 1,934 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,934 | $8.35 | $16,139.23 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260 F1 · price: This transaction was executed in multiple trades at prices ranging from $8.30 to $8.375. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 18:28 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 1,934 | $1.48 | $2,862.32 |
DisclosureSEC source: 0001140361-17-023370 · doc1.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,194 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:08 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001010 · doc1.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 Underlying: Common Stock · 387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:08 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 127 | $12.30 | $1,562.10 |
DisclosureSEC source: 0001140361-17-001010 · doc1.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.